IN2015DN02377A - - Google Patents
Info
- Publication number
- IN2015DN02377A IN2015DN02377A IN2377DEN2015A IN2015DN02377A IN 2015DN02377 A IN2015DN02377 A IN 2015DN02377A IN 2377DEN2015 A IN2377DEN2015 A IN 2377DEN2015A IN 2015DN02377 A IN2015DN02377 A IN 2015DN02377A
- Authority
- IN
- India
- Prior art keywords
- luliconazole
- derivative
- pharmaceutical composition
- composition containing
- amide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Anesthesiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012203293 | 2012-09-14 | ||
PCT/JP2013/073731 WO2014042043A1 (en) | 2012-09-14 | 2013-08-28 | Pharmaceutical composition containing luliconazole |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2015DN02377A true IN2015DN02377A (pt) | 2015-09-04 |
Family
ID=49226452
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2377DEN2015 IN2015DN02377A (pt) | 2012-09-14 | 2013-08-28 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20150238606A1 (pt) |
EP (1) | EP2895164A1 (pt) |
JP (2) | JP5686874B2 (pt) |
CN (1) | CN104619320A (pt) |
IN (1) | IN2015DN02377A (pt) |
RU (1) | RU2621615C2 (pt) |
WO (1) | WO2014042043A1 (pt) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101409792B1 (ko) | 2009-04-09 | 2014-06-19 | 니혼노야쿠가부시키가이샤 | 항진균성 약제학적 조성물 |
EP2416757A2 (en) | 2009-04-09 | 2012-02-15 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
KR101754697B1 (ko) | 2009-08-25 | 2017-07-06 | 가부시키가이샤 폴라 파마 | 항진균성 약제학적 조성물 |
WO2011155640A1 (en) | 2010-06-11 | 2011-12-15 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
JP6265624B2 (ja) * | 2012-05-11 | 2018-01-24 | ロート製薬株式会社 | ルリコナゾール含有外用医薬組成物 |
WO2014042231A1 (en) | 2012-09-14 | 2014-03-20 | Pola Pharma Inc. | Crystal and pharmaceutical preparation containing the same crystal |
JP5460797B1 (ja) * | 2012-09-14 | 2014-04-02 | 株式会社ポーラファルマ | アミド誘導体及び安定性指標としてのその使用 |
CN104619704B (zh) | 2012-09-14 | 2017-12-05 | 宝丽制药股份有限公司 | 表面自由能用于分化评价晶体的用途,基于表面自由能作为指标评价的晶体,以及通过包含所述晶体制备的药物组合物 |
US9199977B2 (en) | 2012-09-14 | 2015-12-01 | Pola Pharma Inc. | Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal |
JP5589110B1 (ja) | 2013-03-08 | 2014-09-10 | 株式会社ポーラファルマ | 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物 |
JP6503627B2 (ja) * | 2013-03-28 | 2019-04-24 | 大正製薬株式会社 | 医薬液体組成物 |
JP5680161B1 (ja) | 2013-09-06 | 2015-03-04 | 株式会社ポーラファルマ | 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物 |
JP6242655B2 (ja) * | 2013-10-29 | 2017-12-06 | リンテック株式会社 | 機能性物質の放出方法、機能性物質の放出用キット及び放出性組成物 |
JP5587488B1 (ja) | 2013-12-12 | 2014-09-10 | 株式会社ポーラファルマ | ルリコナゾールを含有する製剤の評価方法及び指標物質 |
RU2018141796A (ru) * | 2016-05-25 | 2020-06-25 | Гленмарк Фармасьютикалс Лимитед | Стабильные композиции луликоназола для местного применения |
CN107865825B (zh) * | 2016-09-28 | 2022-05-20 | 四川海思科制药有限公司 | 一种卢立康唑外用喷雾剂药物组合物及其制备方法 |
WO2018179170A1 (ja) * | 2017-03-29 | 2018-10-04 | 日本農薬株式会社 | 感染症を治療するための医薬組成物 |
AU2018358372A1 (en) * | 2017-10-30 | 2020-05-28 | Kaken Pharmaceutical Co., Ltd. | External preparation for treating trichophytosis unguium |
CN108143711A (zh) * | 2018-01-13 | 2018-06-12 | 天津双硕医药科技有限公司 | 一种含有卢立康唑的外用乳膏组合物 |
US10898470B1 (en) * | 2019-08-13 | 2021-01-26 | Sato Pharmaceutical Co., Ltd. | Pharmaceutical composition containing antifungal agent as active ingredient |
CN113774390B (zh) * | 2021-08-12 | 2023-08-04 | 上海新阳半导体材料股份有限公司 | 一种用于化学机械抛光后的清洗液及其制备方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2025337B1 (en) | 2006-03-08 | 2014-09-10 | Nihon Nohyaku Co., Ltd. | Pharmaceutical composition for external use |
RU2415669C2 (ru) | 2006-03-08 | 2011-04-10 | Нихон Нохияку Ко., Лтд. | Фармацевтическая композиция для наружного применения |
CA2645070C (en) * | 2006-03-08 | 2014-02-04 | Nihon Nohyaku Co., Ltd. | Pharmaceutical composition for external use |
ES2588188T3 (es) * | 2007-08-27 | 2016-10-31 | Nihon Nohyaku Co., Ltd. | Agente para la dermatitis fúngica |
KR20100075476A (ko) * | 2007-09-05 | 2010-07-02 | 가부시키가이샤 폴라 파마 | 항진균 조성물 |
CN101808637B (zh) | 2007-09-05 | 2013-07-24 | 宝丽制药股份有限公司 | 医药组合物 |
JP5453093B2 (ja) | 2007-09-05 | 2014-03-26 | 株式会社ポーラファルマ | 抗真菌医薬組成物 |
US20090130232A1 (en) * | 2007-11-20 | 2009-05-21 | Mohammed Zahra | Composition and method for treatment of oral inflammation an ulceration |
US8445717B2 (en) * | 2008-11-20 | 2013-05-21 | Chd Bioscience, Inc. | α-Keto alkylperacids and methods for producing and using the same |
WO2010093992A1 (en) * | 2009-02-13 | 2010-08-19 | Topica Pharmaceuticals, Inc | Anti-fungal formulation |
EP2416757A2 (en) * | 2009-04-09 | 2012-02-15 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
KR101409792B1 (ko) * | 2009-04-09 | 2014-06-19 | 니혼노야쿠가부시키가이샤 | 항진균성 약제학적 조성물 |
KR101754697B1 (ko) * | 2009-08-25 | 2017-07-06 | 가부시키가이샤 폴라 파마 | 항진균성 약제학적 조성물 |
WO2011155640A1 (en) * | 2010-06-11 | 2011-12-15 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
KR20140008394A (ko) * | 2011-02-17 | 2014-01-21 | 시에이치디 바이오사이언스 인코포레이티드 | 퍼옥시 α-케토카르복실산을 포함하는 조성물 및 이를 생산하고 사용하기 위한 방법 |
-
2013
- 2013-08-28 RU RU2015108930A patent/RU2621615C2/ru not_active IP Right Cessation
- 2013-08-28 CN CN201380047768.8A patent/CN104619320A/zh active Pending
- 2013-08-28 IN IN2377DEN2015 patent/IN2015DN02377A/en unknown
- 2013-08-28 WO PCT/JP2013/073731 patent/WO2014042043A1/en active Application Filing
- 2013-08-28 EP EP13765810.0A patent/EP2895164A1/en not_active Ceased
- 2013-08-28 JP JP2013176862A patent/JP5686874B2/ja active Active
- 2013-08-28 US US14/427,890 patent/US20150238606A1/en not_active Abandoned
-
2014
- 2014-03-19 JP JP2014056829A patent/JP6215102B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP2014111672A (ja) | 2014-06-19 |
WO2014042043A9 (en) | 2015-05-21 |
CN104619320A (zh) | 2015-05-13 |
US20150238606A1 (en) | 2015-08-27 |
RU2015108930A (ru) | 2016-11-10 |
WO2014042043A1 (en) | 2014-03-20 |
JP6215102B2 (ja) | 2017-10-18 |
JP2014074012A (ja) | 2014-04-24 |
JP5686874B2 (ja) | 2015-03-18 |
EP2895164A1 (en) | 2015-07-22 |
RU2621615C2 (ru) | 2017-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2015DN02377A (pt) | ||
WO2014167554A3 (en) | Composition and formulation of antimicrobial agents, processes thereof and methods for treating microbial infections | |
MX2019009176A (es) | Formulaciones de etanercept estabilizadas con iones metalicos. | |
MX2016010056A (es) | 6-heteroariloxi o 6-ariloxi-quinolina-2-carboxamidas y metodos de uso. | |
NZ627274A (en) | Anesthetic compounds and related methods of use | |
MX355428B (es) | Formas cristalinas del acido [ (4-hidroxi-1-metil-7-fenoxi-isoquin olin-3-carbonil) -amino] -acetico inhibidor de prolil hidroxilasa. | |
MX366954B (es) | Derivados de c17-heteroarilo de ácido oleanólico y métodos de uso de los mismos. | |
NZ630967A (en) | C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof | |
BR112015000229A2 (pt) | formulações aquosas estáveis de etanercept | |
MX357914B (es) | Composiciones y articulos para el cuidado personal. | |
MX2018015938A (es) | Metodos para inhibir la conversion de colina en trimetilamina (tma). | |
WO2014053401A3 (en) | Method of improving plant health | |
MY168438A (en) | Handy calco-magnesian suspension | |
BR112014002940A2 (pt) | uso e composição agroquímica de dibutilamidas de ácido carboxílico | |
MY174149A (en) | Composition for oral cavity | |
SA518391664B1 (ar) | تركيبة لتقييد تكون و/ أو تكتل هيدرات الغاز | |
MX348979B (es) | Agente de control de enfermedades de las plantas. | |
PH12016502544B1 (en) | Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor | |
PH12017500763A1 (en) | Nutritional compositions containing a prebiotic and lactoferrin and uses thereof | |
MX339727B (es) | Composicion farmaceutica que comprende un compuesto de 11-desoxi-prostaglandina y metodo para estabilizar el compuesto. | |
UA109460C2 (uk) | N-гетарилметилпіразолілкарбоксаміди | |
WO2014166836A8 (en) | Growth hormone compound formulation | |
GB2523674A (en) | Compounds as inhibitor of DNA double-strand break repair, methods and applications thereof | |
UA114082C2 (xx) | Спосіб одержання водорозчинних селеноглікопротеїнів та композиція, що їх містить | |
WO2014065640A3 (ko) | 외톨개모자반 추출물 또는 이의 분획물을 유효성분으로 함유하는 염증성 질환 치료 또는 예방용 조성물 |